Why Did Olema Pharmaceuticals Inc (OLMA) Stock See -52.60% Plunge in the Last 90 Days?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $21. Additionally, CapitalOne initiated Overweight rating […]
Olema Pharmaceuticals Inc (OLMA) Stock: Greater Than Its Current Valuation?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $21. Additionally, CapitalOne initiated Overweight rating […]
Why Did Olema Pharmaceuticals Inc (OLMA) Stock Plunge -34.63% Last Week?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $21. Additionally, CapitalOne initiated Overweight rating […]
Olema Pharmaceuticals Inc (OLMA)’s Stock Surge: What You Need to Know
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $21. Additionally, CapitalOne initiated Overweight rating […]
OLMA’s Latest Twist: What’s Fueling the Unexpected Shifts in Olema Pharmaceuticals Inc’s Stock Price?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $21. Additionally, CapitalOne initiated Overweight rating […]
Olema Pharmaceuticals Inc (OLMA) Stock Settles at $11.83: What’s Contributing to This Price Point?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $21. Additionally, CapitalOne initiated Overweight rating […]
Olema Pharmaceuticals Inc (OLMA) Stock: Greater Than Its Current Valuation?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20. Oppenheimer also initiated Outperform rating with a price target of $$21. Additionally, CapitalOne initiated Overweight rating […]
Olema Pharmaceuticals Inc (OLMA) Reported a 0.00% Operating Margin Last Year—What’s the Real Story?
Goldman has recently initiated Olema Pharmaceuticals Inc (OLMA) stock to Buy, as announced on April 2, 2024 according to Finviz. Earlier, on January 30, 2024, Citigroup had initiated the stock to Buy, setting a price target of $20 Oppenheimer also initiated Outperform rating with a price target range from to $21. Additionally, CapitalOne initiated Overweight […]
Olema Pharmaceuticals Inc (OLMA) Stock Still Strong Despite Competition
Goldman raised the price target for the Olema Pharmaceuticals Inc (NASDAQ:OLMA) stock to “a Buy”. The rating was released on April 02, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $21. The stock was initiated by CapitalOne, who disclosed in a research […]
Olema Pharmaceuticals Inc (OLMA) Stock is Just Right Size-Neither Too Big Nor Too Small
Goldman raised the price target for the Olema Pharmaceuticals Inc (NASDAQ:OLMA) stock to “a Buy”. The rating was released on April 02, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $21. The stock was initiated by CapitalOne, who disclosed in a research […]
